Table 1.
PPA | bvFTD | PrAD | |
---|---|---|---|
N | 16 | 10 | 23 |
Age | 68.44 (8.16) | 63.70 (6.61) | 79.46 (8.00) |
Education (Years) | 15.57 (2.79) | 15.90 (2.33) | 13.50 (3.53) |
Duration of disease (Years) | 4.32 (1.74) | 4.90 (2.64) | 5.58 (3.59) |
CDR | 0.53 (0.38) | 1.11 (0.55) | 1.27 (0.49) |
MMSE (max = 30) | 20.88 (7.56) | 24.00 (4.16) | 20.21 (4.58) |
NPI-Q (symptoms, max = 12) | 2.19 (2.23) | 4.22 (2.39) | 3.39 (2.70) |
BNT (max = 60) | 38.92 (20.84) | 41.70 (18.67) | 38.52 (13.49) |
Mean scores (with standard deviations) for CDR, MMSE, NPI-Q (Neuropsychiatric Inventory Questionnaire) and BNT (Boston Naming Test). ANOVA with planned comparisons indicated that PrAD patients were significantly older than PPA and bvFTD patients (p<.005). PPA patients had significantly lower CDR scores and ADL-Q scores than bvFTD or PrAD patients (p<.005).